To allow manufacturers and sponsors of a drug to use alternative testing methods to animal testing to investigate the safety and effectiveness of a biological product.
Reducing Animal Testing Act
This bill removes animal studies as a required component of biosimilar applications and instead allows applicants to use other types of studies to assess toxicity.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.